Search
for

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Dutasterid per Fragebogen in Deutschland?

      in Finasteride/Dutasteride  5 upvotes 1 month ago
      The conversation discusses the high cost and process of obtaining Dutasteride in Germany, with users sharing alternatives and experiences. OP uses Dutasteride for prostate health and beard growth reduction, not for hair loss.

      community 18M 8 months progress 40mg daily dut stack

      in Progress Pictures  112 upvotes 1 year ago
      An 18-year-old is using a high-dose hair loss treatment with 40mg daily dutasteride, finasteride, minoxidil, tretinoin, and topical bicalutamide. Despite health risk concerns, especially liver issues, they report hair regrowth progress and intend to continue the regimen.

      community Dermatologist told me to quit fin after turning 40

      in Finasteride/Dutasteride  194 upvotes 2 years ago
      A dermatologist advised a patient to stop taking finasteride (fin) after turning 40 due to potential risk of aggressive prostate cancer. The patient and others in the conversation debated this advice, discussing the relationship between finasteride, prostate cancer, and hair loss, and considering alternatives like topical finasteride.

      community My dad 61y/o healed from full bald to full head of hair

       178 upvotes 2 years ago
      A user's 61-year-old father regained a full head of hair after four years on dutasteride for his prostate and five months of weight loss and exercise. The user decided to switch from finasteride to dutasteride and continue exercising, inspired by his father's results.

    Learn

    1 / 801 results

      learn Dutasteride

      • Dutasteride side effects: what the label and studies actually report The Avodart label reports impotence in 4.7% and decreased libido in 3.0% of men in the first six months (1.7% and 1.4% on placebo), with new reports falling after month six; those figures come from BPH trials in older men, and the hair-loss trials in younger men run only six months. The label and studies also flag a PSA drop of about half, a small rise in high-grade prostate cancer in one trial, an observational link to depression, and sexual effects that the label says may persist after stopping.